Literature DB >> 21991906

Ipilimumab plus dacarbazine in melanoma.

M Sitki Copur, Angela Obermiller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21991906     DOI： 10.1056/NEJMc1108661

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

Review 1.  Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors.

Authors:  Vidyalakshmi Chandramohan; Duane A Mitchell; Laura A Johnson; John H Sampson; Darell D Bigner
Journal:  Future Oncol       Date:  2013-07       Impact factor: 3.404

2.  FcγRIIB is a T cell checkpoint in antitumor immunity.

Authors:  Clara R Farley; Anna B Morris; Marvi Tariq; Kelsey B Bennion; Sayalee Potdar; Ragini Kudchadkar; Michael C Lowe; Mandy L Ford
Journal:  JCI Insight       Date:  2021-02-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.